Pediatric household contacts (HHCs) of patients with multidrug-resistant TB (MDR-TB) are at high risk of infection and active disease. Evidence of caregiver willingness to give MDR-TB preventive therapy (TPT) to children is limited.METHODS This was a cross-sectional study of HHCs of patients with MDR-TB to assess caregiver willingness to give TPT to children aged \u3c13 years.RESULTS Of 743 adult and adolescent HHCs, 299 reported caring for children aged \u3c13 years of age. The median caregiver age was 35 years (IQR 27-48); 75% were women. Among caregivers, 89% were willing to give children MDR TPT. In unadjusted analyses, increased willingness was associated with TB-related knowledge (OR 5.1, 95% CI 2.3-11.3), belief that one can die of M...
CITATION: Golla, V., et al. 2017. The impact of drug resistance on the risk of tuberculosis infectio...
SETTING: We conducted a qualitative exploration into the palatability and acceptability of a novel f...
CITATION: Seddon, J. A., et al. 2018. Levofloxacin versus placebo for the prevention of tuberculosis...
Drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb) are increasingly recognised as a t...
CITATION: Suryavanshi, N. et al. 2020. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB)...
Drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb) are increasingly recognised as a t...
Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
BACKGROUND: An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacte...
BackgroundAn estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacteri...
BACKGROUND: An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacte...
BACKGROUND: While the prevalence of multidrug-resistant (MDR) tuberculosis (TB) is high among childr...
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug-resistan...
BackgroundAn estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacteri...
Master of Public Health - MPHTuberculosis (TB) continues to be a major cause of ill health and the l...
CITATION: Golla, V., et al. 2017. The impact of drug resistance on the risk of tuberculosis infectio...
SETTING: We conducted a qualitative exploration into the palatability and acceptability of a novel f...
CITATION: Seddon, J. A., et al. 2018. Levofloxacin versus placebo for the prevention of tuberculosis...
Drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb) are increasingly recognised as a t...
CITATION: Suryavanshi, N. et al. 2020. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB)...
Drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb) are increasingly recognised as a t...
Background Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. ...
BACKGROUND: An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacte...
BackgroundAn estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacteri...
BACKGROUND: An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacte...
BACKGROUND: While the prevalence of multidrug-resistant (MDR) tuberculosis (TB) is high among childr...
Inclusion of newly licensed or repurposed drugs in regimens to treat children for multidrug-resistan...
BackgroundAn estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacteri...
Master of Public Health - MPHTuberculosis (TB) continues to be a major cause of ill health and the l...
CITATION: Golla, V., et al. 2017. The impact of drug resistance on the risk of tuberculosis infectio...
SETTING: We conducted a qualitative exploration into the palatability and acceptability of a novel f...
CITATION: Seddon, J. A., et al. 2018. Levofloxacin versus placebo for the prevention of tuberculosis...